Search Results 1071-1080 of 16422 for monoclonal antibody

1. Benralizumab for Eosinophilic Esophagitis - Mayo Clinic

   Receipt of any marketed or investigational biologic (monoclonal or polyclonal antibody) within 4 months or 5 half-lives prior to the date informed consent ...

2. IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma - Mayo Clinic

   or monoclonal antibodies - Contraindication for treatment with investigator's choice therapies as per applicable labelling - Has any other condition that ...

3. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Patients with history of prior daratumumab or another anti-CD38 monoclonal antibody treatment who were not refractory or intolerant to such therapy will be able ...

4. Mayo Clinic study finds dysfunctional white blood cells linked to heightened melanoma risk

   A Mayo Clinic study finds that people with a condition called monoclonal B-cell lymphocytosis (MBL) have a heightened melanoma risk.

5. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

   ... monoclonal antibody as appropriate for the disease): * Ifosfamide/carboplatin/etoposide (ICE) or rituximab/ifosfamide/carboplatin/etoposide (RICE);

6. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Prior immunotherapy (monoclonal antibodies) ≤ 3 weeks prior to registration; ... Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).

7. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

   More information. Publications. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Ordás I. Ingrid; Mould ...

8. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

   composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation

9. X-linked agammaglobulinemia - Symptoms and causes - Mayo Clinic

   When these antibodies leave their systems, the babies begin to get repeat bacterial infections. ... People with the condition can't produce proteins called ...

10. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

    Anti-CD20 monoclonal antibody;; An anthracycline-containing chemotherapy regimen. No evidence, suspicion, and/or history of central nervous system (CNS) ...